25 May 2013
Keywords: Orphan drugs, Designation, Pricing, Funding, Japan, South Korea, Taiwan, Singapore, Australia
Article | 08 February 2010
It is estimated that 6%-10% of the world’s population will suffer from a rare disease at one point in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 February 2010
24 May 2013
© 2013 thepharmaletter.com